NO981135D0 - Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds - Google Patents

Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Info

Publication number
NO981135D0
NO981135D0 NO981135A NO981135A NO981135D0 NO 981135 D0 NO981135 D0 NO 981135D0 NO 981135 A NO981135 A NO 981135A NO 981135 A NO981135 A NO 981135A NO 981135 D0 NO981135 D0 NO 981135D0
Authority
NO
Norway
Prior art keywords
tetrahydro
acid addition
addition salts
benzazepine compounds
benzazepine
Prior art date
Application number
NO981135A
Other languages
Norwegian (no)
Other versions
NO981135L (en
Inventor
Louis Brammer Hansen
Rolf Emil Amsler
Scott Eugene Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO981135L publication Critical patent/NO981135L/en
Publication of NO981135D0 publication Critical patent/NO981135D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981135A 1995-09-15 1998-03-13 Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds NO981135D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK103095 1995-09-15
PCT/DK1996/000383 WO1997010239A1 (en) 1995-09-15 1996-09-12 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
NO981135L NO981135L (en) 1998-03-13
NO981135D0 true NO981135D0 (en) 1998-03-13

Family

ID=8100205

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981135A NO981135D0 (en) 1995-09-15 1998-03-13 Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Country Status (13)

Country Link
EP (1) EP0850237A1 (en)
JP (1) JPH11512403A (en)
KR (1) KR19990044648A (en)
CN (1) CN1200121A (en)
AU (1) AU700596B2 (en)
BR (1) BR9610162A (en)
CA (1) CA2231848A1 (en)
CZ (1) CZ77898A3 (en)
HU (1) HUP9900746A3 (en)
IL (1) IL123602A0 (en)
NO (1) NO981135D0 (en)
PL (1) PL325514A1 (en)
WO (1) WO1997010239A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK23392D0 (en) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocyclic Compounds, Their Uses and Preparation

Also Published As

Publication number Publication date
PL325514A1 (en) 1998-08-03
AU700596B2 (en) 1999-01-07
WO1997010239A1 (en) 1997-03-20
BR9610162A (en) 1999-01-05
JPH11512403A (en) 1999-10-26
CZ77898A3 (en) 1998-07-15
NO981135L (en) 1998-03-13
CA2231848A1 (en) 1997-03-20
CN1200121A (en) 1998-11-25
KR19990044648A (en) 1999-06-25
MX9802000A (en) 1998-08-30
HUP9900746A2 (en) 1999-09-28
IL123602A0 (en) 1998-10-30
HUP9900746A3 (en) 1999-11-29
AU6923596A (en) 1997-04-01
EP0850237A1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
ATE211131T1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
NO981800D0 (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
DE59609043D1 (en) Solid solutions of 1,4-diketopyrrolopyrroles
IT1272922B (en) PROCEDURE FOR THE PREPARATION OF METALLOCENIC COMPOUNDS
DE69618045D1 (en) Clavulanic acid salt
EE03393B1 (en) Process for the preparation of enantiomerically pure azetidine-2-carboxylic acid
NO974155D0 (en) A novel process for the preparation of 2,3-dihydrobenzofuranol derivatives
PT831820E (en) ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS AS A SOLUTION
FI941149A0 (en) Derivatives of 2,4-diamino-3-hydroxycarboxylic acid
NO940171D0 (en) Procedure for continuous preparation of dimethoxyethane
NO961783L (en) 5-arylisoxazol-4-yl-substituted 2-aminocarboxylic acid compounds
NO995388D0 (en) Process for the preparation of formylphosphonic acid
NO981135D0 (en) Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds
FI932396A0 (en) For the preparation of diphelic acid with 2,3-hydroxymethylcyclobutanol
FI961520A (en) Heribicidal azabisphosphonic acid compounds
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid
PT1133496E (en) CRYSTALLINE A MODIFICATION OF 8-CYANO-1-CYCLOPROPYL-7- (1S, 6S-2,8-DIAZABICYCLO-4,3,0-NONAN-8-YL) -6-FLUORO-1,4- DIHYDRO- 4-OXO-3-KINOLINOCARBOXYLIC ACID
DE59603417D1 (en) 3,3-Dioxy-4,4,4-trifluorobutyric acid derivatives
BR9408162A (en) 2,3,5,6-tetrafluorbenzoic acid derivatives
DE69611546D1 (en) PREPARATION OF 2,6-DIMETHYLNAPHTHALINE
NO963218D0 (en) Para-hydroxyphenylacetic acid for reducing insecticide repellency
IT1284797B1 (en) PROCEDURE FOR THE PRODUCTION OF PYRAZINE COMPOUNDS.
FR2737894B1 (en) PROCESS FOR THE PREPARATION OF ALKYLETAIN FLUORIDES
DE69311355D1 (en) PERSOIC ACID COMPOUNDS